You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Xultophy

Showing 1 - 25 of 32
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Italy to Understand How Dose Check App Used With Xultophy®

Not yet recruiting
  • Diabetes Mellitus, Type 2
  • Catanzaro, Cz, Italy
  • +1 more
Oct 27, 2023

(rPMS) Study of Xultophy® to Evaluate Safety and Effectiveness

Enrolling by invitation
  • Diabetes Mellitus, Type 2
  • Xultophy® (insulin degludec/liraglutide)
  • Daejeon, Cheongsa-ro, Seo-gu, Korea, Republic of
  • +9 more
Mar 21, 2022

Looking at How Xultophy® Works in People With Type 2 Diabetes in

Completed
  • Diabetes Mellitus, Type 2
  • Insulin degludec/liraglutide
  • AbuDhabi, United Arab Emirates
  • +2 more
Sep 21, 2021

Looking at Blood Sugar Control in People With Type 2 Diabetes

Not yet recruiting
  • Diabetes Mellitus, Type 2
  • (no location specified)
Jul 27, 2022

Looking at Long Term Blood Sugar Control in People With Type 2

Enrolling by invitation
  • Diabetes Mellitus, Type 2
  • Aichi, Japan
  • +38 more
Mar 21, 2022

Looking at Long-term Blood Sugar Control in People With Type 2

Enrolling by invitation
  • Diabetes Mellitus, Type 2
  • Insulin degludec and liraglutide (IDegLira)
  • Alessandria, Italy
  • +27 more
Aug 16, 2021

Glycaemic Control and Other Clinical Parameters in Adult Type 2

Completed
  • Diabetes Mellitus, Type 2
  • Medellín, Antioquia, Colombia
  • +5 more
Nov 4, 2022

Type 2 Diabetes Trial in Cleveland (Semaglutide, Insulin Degludec, Insulin aspart)

Recruiting
  • Type 2 Diabetes
  • Cleveland, Ohio
    Cleveland Clinic
Jul 18, 2022

Diabetes, Type 2 Treated With Insulin Trial in Bogotá (insulin degludec + liraglutide, Insulin Glargine - Insulin Aspart)

Recruiting
  • Diabetes Mellitus, Type 2 Treated With Insulin
  • insulin degludec + liraglutide
  • Insulin Glargine - Insulin Aspart
  • Bogotá, Colombia
    Hospital Universitario San Ignacio
Mar 2, 2023

Type 2 Diabetes Trial in Canada (IDegLira, insulin degludec, Metformin)

Recruiting
  • Type 2 Diabetes Mellitus
  • Calgary, Alberta, Canada
  • +7 more
Mar 16, 2022

Type2 Diabetes Trial in Roma (IDegLira)

Completed
  • Type2 Diabetes
  • Roma, Italy
    Stefano Rizza
Aug 2, 2021

Four Second Line Pharmacological Strategies in Type 2 Diabetes

Active, not recruiting
  • Cardiovascular Events
  • +2 more
  • SGLT2 inhibitor
  • +3 more
  • Boston, Massachusetts
    Brigham and Women's Hospital
Feb 17, 2022

Xultophy® inAdult Real-world Population With Type 2 Diabetes

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec/liraglutide
  • Wien, Austria
  • +4 more
Jan 11, 2018

Diabetes, Diabetes, Type 2 Trial in Beijing (insulin degludec/liraglutide, insulin degludec, liraglutide)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec/liraglutide
  • +2 more
  • Beijing, Beijing, China
    Novo Nordisk Investigational Site
Nov 15, 2019

Non-interventional, Post Marketing Surveillance Study of

Withdrawn
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec/liraglutide
  • (no location specified)
Sep 1, 2017

Diabetes, Diabetes, Type 2 Trial in Japan (Insulin degludec/liraglutide, Insulin degludec)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Insulin degludec/liraglutide
  • Insulin degludec
  • Asahikawa-shi, Hokkaido, Japan
  • +37 more
Mar 10, 2021

Diabetes, Diabetes, Type 2 Trial in Japan (insulin degludec/liraglutide, insulin degludec, liraglutide)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec/liraglutide
  • +2 more
  • Adachi-ku, Tokyo, Japan
  • +75 more
Mar 10, 2021

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, insulin glargine)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec/liraglutide
  • insulin glargine
  • Glendale, Arizona
  • +87 more
Aug 10, 2020

Diabetes, Diabetes, Type 2 Trial in China (Insulin degludec/liraglutide, Insulin degludec, Liraglutide)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Insulin degludec/liraglutide
  • +2 more
  • Hefei, Anhui, China
  • +36 more
Jun 11, 2020

Diabetes, Diabetes, Type 2 Trial in China, Hong Kong (Insulin degludec/liraglutide, Insulin degludec)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Insulin degludec/liraglutide
  • Insulin degludec
  • Hefei, Anhui, China
  • +36 more
Mar 18, 2020

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, insulin glargine)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec/liraglutide
  • insulin glargine
  • Fresno, California
  • +90 more
Dec 7, 2018

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, insulin degludec)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec/liraglutide
  • insulin degludec
  • Huntsville, Alabama
  • +85 more
Dec 7, 2018

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, liraglutide, exenatide)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec/liraglutide
  • +2 more
  • Birmingham, Alabama
  • +108 more
Dec 7, 2018

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, insulin glargine)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec/liraglutide
  • insulin glargine
  • Muscle Shoals, Alabama
  • +142 more
Nov 8, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, insulin glargine, insulin aspart)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec/liraglutide
  • +2 more
  • Tuscumbia, Alabama
  • +116 more
Mar 1, 2018